BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33323766)

  • 1. A Comprehensive Evaluation of Risk Factors for Pneumocystis jirovecii Pneumonia in Adult Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
    Permpalung N; Kittipibul V; Mekraksakit P; Rattanawong P; Nematollahi S; Zhang SX; Steinke SM
    Transplantation; 2021 Oct; 105(10):2291-2306. PubMed ID: 33323766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
    Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
    Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis and treatment of Pneumocystis Jirovecii pneumonia after solid organ transplantation.
    Brakemeier S; Pfau A; Zukunft B; Budde K; Nickel P
    Pharmacol Res; 2018 Aug; 134():61-67. PubMed ID: 29890253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014.
    Cooley L; Dendle C; Wolf J; Teh BW; Chen SC; Boutlis C; Thursky KA
    Intern Med J; 2014 Dec; 44(12b):1350-63. PubMed ID: 25482745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?
    Liebling M; Rubio E; Ie S
    Expert Rev Respir Med; 2015 Apr; 9(2):171-81. PubMed ID: 25771943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.
    Zhang Y; Zheng Y
    Rheumatol Int; 2014 Dec; 34(12):1765-71. PubMed ID: 24948376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta-analysis.
    Hosseini-Moghaddam SM; Krishnan RJ; Guo H; Kumar D
    Clin Transplant; 2018 Aug; 32(8):e13339. PubMed ID: 29956379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
    Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
    Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for Pneumocystis jirovecii pneumonia after kidney transplantation: A systematic review and meta-analysis.
    Cheng B; Qi C; Zhang S; Wang X
    Clin Transplant; 2024 May; 38(5):e15320. PubMed ID: 38690617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs.
    Schmajuk G; Jafri K; Evans M; Shiboski S; Gianfrancesco M; Izadi Z; Patterson SL; Aggarwal I; Sarkar U; Dudley RA; Yazdany J
    Semin Arthritis Rheum; 2019 Jun; 48(6):1087-1092. PubMed ID: 30449650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of Pneumocystis jirovecii prophylaxis use among pediatric solid organ transplant providers.
    Paulsen G; Michaels MG; Danziger-Isakov L; Dipchand AI; Green M; McCulloch M
    Pediatr Transplant; 2020 Feb; 24(1):e13609. PubMed ID: 31713958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.
    Diri R; Anwer F; Yeager A; Krishnadasan R; McBride A
    Transpl Infect Dis; 2016 Feb; 18(1):63-9. PubMed ID: 26606757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Fishman JA; Gans H;
    Clin Transplant; 2019 Sep; 33(9):e13587. PubMed ID: 31077616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
    Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation.
    Yang P; Zhu X; Liang W; Cai R
    Mycoses; 2021 May; 64(5):495-502. PubMed ID: 33368732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.